Tag: End of Phase 2 Meeting

May 9, 2018

ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update

ARCA biopharma (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported...
May 9, 2018

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

Kura Oncology (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter...
March 13, 2018

Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results

Kura Oncology (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today provided a regulatory...
February 26, 2018

Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results

Endocyte (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, provided an update on its corporate strategy and...
January 10, 2018

Biotech Showcase Conference: Notes from the Floor, Day Two

Miss the Biotech Showcase Conference in San Fransisco? Don't worry, the Investing News Network was there on the floor of...
December 4, 2017

Oncolytics Biotech Will Present at Upcoming Conference

Oncolytics Biotech announced Dr. Matt Coffey, their president and CEO will be presenting an update on pelareorep in a clinical...
November 8, 2017

Oncolytics Biotech Reports Q3 2017 Financials

Oncolytics Biotech announced its financial results for the third quarter of 2017.